Myasthenia gravis and multiple sclerosis: an unusual combination of diseases.
D000328:Adult; D001921:Brain / Q000473:pathology; D003711:Demyelinating Diseases; D004172:Diplopia / Q000209:etiology; D004491:Edrophonium / Q000627:therapeutic use; D004569:Electroencephalography; D005260:Female; D006048:Gold Colloid, Radioactive; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications* / Q000473:pathology; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D009388:Neostigmine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012607:Scotoma / Q000209:etiology; D013934:Thymectomy; D005719:gamma-Globulins / Q000134:cerebrospinal fluid
D006048:Gold Colloid, Radioactive; D005719:gamma-Globulins; D009388:Neostigmine; D004491:Edrophonium; D011729:Pyridostigmine Bromide; D011241:Prednisone